Your browser doesn't support javascript.
Association of Pre-Existing Comorbidities with Disease Severity Among COVID-19 Patients in Eastern Ethiopia.
Merga, Bedasa Taye; Ayana, Galana Mamo; Raru, Temam Beshir; Alemu, Addisu; Negash, Belay; Bekana, Miressa; Birhanu, Abdi; Dessie, Yadeta.
  • Merga BT; School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Ayana GM; School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Raru TB; School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Alemu A; School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Negash B; School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Bekana M; School of Medicine, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Birhanu A; School of Medicine, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
  • Dessie Y; School of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Infect Drug Resist ; 15: 2825-2834, 2022.
Article in English | MEDLINE | ID: covidwho-1933455
ABSTRACT

Background:

Comorbidities and advanced age increase the risk of severe outcomes of COVID-19. In order to shift the possible unfavorable treatment outcome in patients with chronic illnesses, information related to the prevalence of chronic illness and its effect on severity of COVID-19 infection has paramount importance.

Objective:

This study was aimed at assessing the prevalence of comorbidities and associated severity among COVID-19 patients admitted to COVID-19 treatment center, eastern Ethiopia.

Methods:

An institution-based cross-sectional study design was employed among 422 COVID-19 patients admitted to COVID-19 treatment center, eastern Ethiopia from April 10, 2020, to August 10, 2021. Binary logistic regression was fitted to identify comorbidities and other factors associated with severe clinical outcome, associations were presented with adjusted odds ratios (AORs) and 95% confidence intervals (CIs). In all analyses statistical significance were declared at p-value <0.05.

Results:

More than half (52.4%) of the COVID-19 patients were presented with comorbid conditions. One third (34.6%) of the admitted COVID-19 patients were in severe clinical stages. Marital status (AOR=4.56; 95% CI 1.40, 14.76), hypertension (AOR=2.08; 95% CI 1.09, 3.97), diabetes mellitus (AOR=3.31; 95%1.84, 5.98), and cardiovascular diseases (AOR=4.22; 95% CI 2.18, 8.15) were identified as factors associated with severe clinical stages.

Conclusion:

The comorbid conditions such as diabetes, hypertension, and cardiovascular diseases, and marital status were identified as significant predictors of severe outcomes of COVID-19. Therefore, identifying the people with chronic comorbidities as a risk group would help to anticipate and prevent the serious outcomes of COVID-19 infection.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Infect Drug Resist Year: 2022 Document Type: Article Affiliation country: IDR.S362140

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Infect Drug Resist Year: 2022 Document Type: Article Affiliation country: IDR.S362140